3M Company (MMM) — Company Research
Last Updated: 2 November 2026
3M Company (NYSE: MMM) is a diversified industrial manufacturer that turns materials science into products across safety, industrial, electronics, transportation and consumer markets. Since spinning off its Health Care business as Solventum in April 2024 it has been a smaller, more industrial company, and under Chairman and CEO William (Bill) Brown it is in the middle of an operating turnaround while paying down PFAS and Combat Arms Earplugs liabilities. Q3 2026 results on 20 Oct 2026 showed adjusted EPS up 12% to $2.50, and full-year 2026 adjusted EPS guidance was raised to $9.10–$9.15. Data-centre products, helped by new agreements with Amazon and AWS in October 2026, are becoming a visible growth driver. This refresh uses 3M's earnings releases and SEC filings.
1. Company Snapshot
| Field | Value |
|---|---|
| Company | 3M Company |
| Ticker / Exchange | MMM / NYSE |
| Sector | Industrials (diversified manufacturing) |
| CEO / Leadership | William (Bill) Brown (Chairman & CEO); Anurag Maheshwari (EVP & CFO) |
| Employees | About 60,500 at 31 Dec 2025 (about 22,500 in the US and 38,000 elsewhere) |
| Revenue (FY2025) | $24,948m net sales (+1.5%) |
| GAAP EPS / Adjusted EPS (FY2025) | $6.00 / $8.06 as originally reported ($8.20 on the revised 2026 basis) |
| FY2026 guidance (20 Oct 2026) | Adjusted EPS $9.10–$9.15; adjusted organic growth above 3.5%; adjusted free cash flow about $4.8bn |
| Market cap | ~$90.1bn ($174.34 close on 30 Oct 2026 × 516.7m shares at 30 Sep 2026) |
| Dividend | $0.78 per quarter ($3.12 annualised) |
2. Investment Thesis: Bull vs Bear
Bull Case
- Turnaround delivering earnings growth: Q3 2026 adjusted EPS rose 12% to $2.50 and full-year adjusted EPS guidance was raised to $9.10–$9.15 from $8.95–$9.10 (revised basis).
- Data-centre growth engine: Data-centre revenue is expected to reach about $700m in 2026 from about $550m in 2025, backed by Microsoft and AWS partnerships and an Amazon warrant tied to $6bn of cumulative purchases.
- Innovation pipeline restored: 87 new products launched in Q3 2026 (up 24%), with more than 350 expected in 2026 toward 1,000 launches through 2027.
- Margin and productivity gains: Q3 2026 adjusted operating margin was 26.2% and gross margin rose 230bp, while 16 sites have been closed in 2026.
- Legal liabilities shrinking: Combat Arms Earplugs accruals fell to $1.1bn at 30 Sep 2026 from $2.4bn at the end of 2025, and 3M completed its exit from PFAS manufacturing by the end of 2025.
Bear Case
- Large PFAS liabilities remain: 3M carried $7.5bn of PFAS-related environmental liabilities at 30 Sep 2026, on top of public water system settlement payments running to 2036.
- Thin underlying growth: Continuing-operations net sales of $24,948m in FY2025 were below the restated $26,161m of FY2022, and Q3 2026 GAAP organic growth was just 0.2%.
- GAAP cash flow still weighed down: FY2025 operating cash flow was only $2,306m after litigation payments, and about $2.0bn of litigation and PFAS-exit payments were made in the first nine months of 2026.
- Debt rising: Total debt rose to about $15.0bn at 30 Sep 2026 from $12.6bn at the end of 2025 after the Madison Fire & Rescue deal and $3.2bn of buybacks.
- Cost inflation: Management flagged about $185m of oil-related cost inflation that pricing has to offset.
3. Business Segments
3M reports three business segments. Percentages below use FY2025 total net sales of $24,948m (Q4 2025 release); Corporate and Other made up the remaining ~1.5%. From 2026, manufactured PFAS products and some special items moved into Corporate and the segments were recast.
| Segment | % of revenue | What it is |
|---|---|---|
| Safety & Industrial | 45.6% ($11,384m) | Abrasives, adhesives and tapes, personal safety equipment, electrical markets and industrial specialties. |
| Transportation & Electronics | 33.2% ($8,272m) | Materials, films and components for automotive, aerospace, electronics, displays, semiconductors and data-centre optical connectivity. |
| Consumer | 19.7% ($4,920m) | Home, office and retail brands such as Post-it, Scotch, Command and Filtrete. |
4. Business Model & Moat
How it makes money. 3M sells products built on shared technology platforms in adhesives, abrasives, films, optics and filtration. Many are low-cost consumables designed into customers' production lines or safety rules, so demand tends to repeat.
The operating reset. Under Bill Brown, 3M is focusing on on-time delivery, equipment effectiveness and cost of poor quality, closing sites and speeding up product launches. In Q3 2026 equipment effectiveness improved 20bp, cost of poor quality improved 40bp and gross margin rose 230bp. Cross-selling wins of $140m have already beaten the original three-year goal of $100m.
Capital allocation. Adjusted free cash flow funds a $3.12 annual dividend and heavy buybacks ($3,225m in the first nine months of 2026), while litigation payments are made from operating cash flow. 3M also holds a Solventum stake worth $2,254m at 30 Sep 2026, which it expects to sell within five years of the April 2024 spin-off.
5. Financial Health
Annual figures are continuing operations as restated in 3M's FY2024 and FY2025 10-K filings (SEC XBRL), so the Health Care business spun off as Solventum is excluded. 3M has not published a restated FY2021 figure, so the table starts at FY2022. Long-term debt is the non-current year-end balance.
| Fiscal Year | Revenue ($m) | YoY % | GAAP EPS | Adjusted EPS | Dividend/share | Long-term debt (YE) |
|---|---|---|---|---|---|---|
| FY2022 | $26,161m | n/a (no restated FY2021) | $7.07 | $10.10† | $5.96 | $14,001m |
| FY2023 | $24,610m | −5.9% | −$15.17 | $9.24† | $6.00 | $13,088m |
| FY2024 | $24,575m | −0.1% | $7.26 | $7.30 | $3.61 | $11,125m |
| FY2025 | $24,948m | +1.5% | $6.00 | $8.06 | $2.92 | $10,932m |
† FY2022 and FY2023 adjusted EPS are total-company figures including Health Care, as originally reported; 3M has not published post-spin restatements. GAAP EPS is from continuing operations. The FY2023 GAAP loss reflects the PFAS public water system and Combat Arms Earplugs settlement charges. The FY2024 dividend was cut after the Solventum spin-off. On the revised 2026 non-GAAP basis, which also excludes intangible amortisation, FY2024 and FY2025 adjusted EPS are $7.45 and $8.20.
Quarterly results, most recent first.
| Quarter / Half | Revenue | Adjusted EPS | GAAP EPS |
|---|---|---|---|
| Q3 2026 | $6,584m | $2.50‡ | $2.63 |
| Q2 2026 | $6,500m | $2.44‡ | $1.78 |
| Q1 2026 | $6,030m | $2.18‡ | $1.23 |
| Q4 2025 | $6,133m | $1.83 | $1.07 |
| Q3 2025 | $6,517m | $2.19 | $1.55 |
| Q2 2025 | $6,344m | $2.16 | $1.34 |
| Q1 2025 | $5,954m | $1.88 | $2.04 |
| FY2025 total | $24,948m | $8.06 | $6.00 |
‡ 2026 quarters are on the revised non-GAAP basis that excludes intangible amortisation (about +$0.04 a quarter); 2025 quarters are as originally reported. Q3 2026 GAAP EPS includes a $0.60 gain on the Solventum stake.
Cash flow and balance sheet. FY2025 operating cash flow was $2,306m, capital expenditure $910m and depreciation and amortisation $1,308m; adjusted free cash flow, which excludes litigation and PFAS-exit payments, was $4,374m. For the nine months to 30 Sep 2026, operating cash flow was $2,046m, capex $704m and D&A $997m. At 30 Sep 2026 3M had $12,558m of long-term debt, $2,439m of current debt and $4,835m of cash and cash equivalents. The 2026 guidance calls for adjusted operating cash flow of about $5.9bn and capex of about $1.1bn. Follow the shares on ChartsView Live Charts.
6. Valuation
Raw metrics, November 2026. Not opinions on whether the stock is cheap or expensive.
| Metric | Value |
|---|---|
| Market cap | ~$90.1bn ($174.34 close on 30 Oct 2026 × 516.7m shares at 30 Sep 2026) |
| Trailing P/E (GAAP) | ~26.0x ($174.34 / TTM GAAP EPS $6.71, four quarters to Q3 2026). On TTM adjusted EPS of $8.99 (revised basis) the multiple is ~19.4x. |
| P/E (forward) | ~19.1x ($174.34 / $9.125, midpoint of management's FY2026 adjusted EPS guidance of $9.10–$9.15) |
| P/S (TTM) | ~3.6x (~$90.1bn / TTM net sales $25,247m) |
| Enterprise value | ~$100.3bn (market cap ~$90.1bn + total debt ~$15.0bn [long-term $12,558m + current $2,439m] − cash ~$4.8bn, per 30 Sep 2026 balance sheet; excludes the $2.25bn Solventum stake) |
| EV/EBITDA (TTM) | ~16.3x (EV ~$100.3bn / EBITDA ~$6.16bn; EBITDA = TTM GAAP operating income $4,735m + TTM D&A $1,427m). GAAP operating income includes litigation and transformation charges. |
| P/FCF | ~33.7x on GAAP free cash flow (~$90.1bn / TTM FCF ~$2.68bn; FCF = TTM operating CF $3,629m − capex $952m). GAAP FCF is cut by litigation payments; on guided 2026 adjusted FCF of ~$4.8bn the multiple is ~18.8x. |
| Dividend yield | ~1.8% ($3.12 annualised / $174.34) |
| 52-week high | $184.90 |
| 52-week low | $139.34 |
| Short interest (% of float) | 1.88% (9.68m shares, settlement 30 Sep 2026) |
| Days to cover | 3.1 |
7. What Are They Building
- Data-centre connectivity: Data-centre revenue is expected at about $700m in 2026 versus about $550m in 2025. Expanded Beam Optical (EBO) revenue is expected at about $40m in 2026, rising to $80–$100m in 2027, after ferrule capacity doubled to more than 10m a year. 3M has partnerships with Microsoft and AWS and proof-of-concept work with five hyperscalers.
- Amazon and GSEO agreements: On 19 Oct 2026 3M issued Amazon a warrant for up to 3,162,015 shares at $164.89, about 85% of which vests as Amazon reaches $6bn of cumulative purchases of optical connectivity and data-centre products. It also agreed an EBO collaboration with GSEO, including a stake of about 4.7%.
- New product launches: 84, 92 and 87 launches in Q1, Q2 and Q3 2026, on track for more than 350 this year and toward the Investor Day goal of 1,000 through 2027. Sales from products launched in the past five years were nearly $3bn in the first nine months of 2026, up 34%.
- Fire safety platform: The Madison Fire & Rescue acquisition closed in July 2026 ($1.95bn headline price) through a venture with Bain Capital in which 3M holds 50.1%. It now reports as the Fire Safety and Rescue division (3M Sentorum) and added about $90m of Q3 sales.
- Footprint simplification: 16 manufacturing and distribution sites closed in 2026 so far, with action planned on 10 more over the next 12 months; the precision grinding and finishing business and Dyneon GmbH were sold in Q2 2026.
8. Peer Comparison
| Peer | Market cap (Oct 2026) | Key 2025 metric |
|---|---|---|
| Illinois Tool Works (ITW) | ~$79.2bn | FY2025 revenue $16,044m; operating margin 26.3% (10-K) |
| Honeywell (HON) | ~$69.2bn | FY2025 sales $37,442m including Aerospace, which was spun off on 29 Jun 2026 (Q4 2025 release) |
| DuPont (DD) | ~$18.9bn | FY2025 continuing-operations net sales $6,849m after the Qnity spin-off (Q4 2025 release) |
| Avery Dennison (AVY) | ~$13.8bn | FY2025 net sales about $8.9bn; adjusted EPS $9.53 (Q4 2025 release) |
Market caps at the 30 Oct 2026 close.
9. Insider Activity
Form 4 filings show no open-market purchases by 3M insiders in 2026, and no transactions by Chairman and CEO William Brown in the list below. None of the sales were made under a 10b5-1 plan. Most were option exercises with immediate sale, or shares withheld to pay tax on vesting awards.
| Name | Date | Type | Shares | Price | Value | Plan Type |
|---|---|---|---|---|---|---|
| Christian Goralski (Group President) | 07 Oct 2026 | Shares withheld for tax | 1,724 | $162.12 | ~$0.28m | Not a market sale |
| Anurag Maheshwari (EVP & CFO) | 01 Oct 2026 | RSU vest; shares withheld for tax | 4,991 withheld | $163.02 | ~$0.81m | Not a market sale |
| Beatriz Chavez Rodriguez (Group President) | 05 Aug 2026 | Sale | 3,635 | $182.51 | ~$0.66m | Not under a 10b5-1 plan |
| John Banovetz (EVP) | 23 Jul 2026 | Option exercise & sale | 7,880 | $170.44 | ~$1.34m | Not under a 10b5-1 plan |
| Kevin Rhodes (EVP, Chief Legal Officer) | 22 Jul 2026 | Option exercise & sale | 7,669 | $171.20 | ~$1.31m | Not under a 10b5-1 plan |
| Christian Goralski (Group President) | 22 Jul 2026 | Option exercise & sale | 4,902 | $170.46 | ~$0.84m | Not under a 10b5-1 plan |
| Zoe Dickson (EVP, Chief HR Officer) | 09 Feb 2026 | Option exercise & sale | 20,519 | $169.97 | ~$3.49m | Not under a 10b5-1 plan |
10. Key Risks
- Material litigation (PFAS): 3M had $7.5bn of PFAS-related environmental liabilities at 30 Sep 2026, and the $10.5–$12.5bn public water system settlement is paid through 2036, with the final amount still under review. Personal-injury claims remain unresolved.
- Combat Arms Earplugs and other claims (Legal): Up to $6.0bn is payable over 2023–2029 ($1.1bn still accrued at 30 Sep 2026), plus respirator and asbestos accruals of about $0.5bn.
- Weak organic growth (Commercial): Continuing-operations sales have not grown since FY2022, and industrial, electronics, automotive and consumer demand could soften.
- Execution of the turnaround (Operational): Margin and earnings targets depend on continued site closures, productivity gains and faster product launches.
- Rising debt and venture obligations (Financial): Total debt rose to about $15.0bn at 30 Sep 2026, and Bain Capital can require 3M to buy its interest in the Madison venture after five years.
- Input costs and currency (Financial): About $185m of oil-related inflation must be offset by pricing, and as a global manufacturer 3M's reported results move with exchange rates.
11. Recent Developments
- 21 Oct 2026 — AWS collaboration. 3M and AWS announced a collaboration on optical connectivity, which 3M says will support more than 500 jobs.
- 20 Oct 2026 — Q3 2026 results and guidance raised. Sales of $6,584m, adjusted EPS up 12% to $2.50 and adjusted organic growth of 3.3%. Full-year adjusted EPS guidance was raised to $9.10–$9.15, and 3M switched to a non-GAAP basis that excludes intangible amortisation.
- 19 Oct 2026 — Amazon warrant and GSEO stake. 3M issued Amazon a warrant for up to 3.16m shares linked to purchases of data-centre products and agreed an EBO collaboration with GSEO.
- 14 Aug 2026 — Quarterly dividend declared. The board declared the Q3 dividend of $0.78 per share.
- 01 Jul 2026 — Madison Fire & Rescue deal closed. The $1.95bn acquisition, done through a 50.1%-owned venture with Bain Capital, created the Fire Safety and Rescue division.
12. Key Dates
- Expected Nov 2026 — Q4 2026 dividend declaration (last year's was declared 04 Nov 2025 and paid 12 Dec 2025)
- Expected Jan 2027 — Q4 and full-year 2026 results with 2027 guidance (date not yet announced; FY2025 results came on 20 Jan 2026)
- TBC — Sale of the remaining Solventum stake (3M expects to exit within five years of the April 2024 spin-off)
Track scheduled macro releases on the ChartsView Economic Calendar, and discuss 3M with other members on the ChartsView Forum.
Disclaimer: This research is produced by ChartsView for educational and informational purposes only. It does not constitute financial advice or a recommendation to buy or sell any security. All information is sourced from publicly available company filings, press releases, and official data. ChartsView does not use analyst opinions or third-party ratings. Always conduct your own due diligence and consider your personal financial situation before making investment decisions. Past performance is not indicative of future results.
Loading research report…
13. Thesis Verdict
The central thesis. 3M sells materials-science products across Safety & Industrial, Transportation & Electronics and Consumer markets, many of them consumables built into customers' processes. FY2025 net sales rose 1.5% to $24,948m, with adjusted EPS of $8.06 and adjusted free cash flow of $4,374m. On 20 Oct 2026 management raised FY2026 adjusted EPS guidance to $9.10–$9.15, with adjusted organic growth above 3.5%. The main structural driver is data-centre connectivity, where revenue is expected at about $700m in 2026, backed by new Amazon and AWS agreements.
What would confirm or break it. The case would be confirmed by continued margin expansion, faster product launches and data-centre growth turning into sustained organic growth. It would be undermined by additional PFAS liabilities beyond the $7.5bn accrued, further litigation cash outflows, or rising debt and stagnant continuing-operations sales.
Watchpoints
- ConfirmsSubsequent earnings and filings reinforcing the figures presented in this report.
- ConfirmsEvidence supporting the "Turnaround delivering earnings growth:" thesis continuing to build across subsequent filings.
- InvalidatesMaterialisation of the "Material litigation (PFAS):" risk, or any disclosure that fundamentally alters the capital-return or growth profile stated by management.
Diagnostic grid
Generated by ChartsView research tooling. Thesis strength measures how well the evidence in this report supports the company's stated thesis — it is NOT a buy/sell rating or price target. ChartsView is not authorised by the FCA to provide regulated investment advice. Generated 2 Nov 2026.
Open MMM on TradingView Affiliate link: ChartsView may earn a commission if you subscribe to TradingView through it.
ChartsView forum
Talk about 3M (MMM)
Got a view on MMM, or a question about it? Nobody has started a thread on 3M yet. Ask on the forum and other traders can reply.